Evidence map›Paper›PMID 39748003›Full record

ArticleScientific reports2025

Drug molecular representations for drug response predictions: a comprehensive investigation via machine learning methods.

Meisheng Xiao, Qianhui Zheng, Paul Popa, Xinlei Mi, Jianhua Hu, Fei Zou, Baiming Zou

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Meisheng XiaoDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, USA.
Qianhui ZhengDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, USA.
Paul PopaSystem2, New York, NY, USA.
Xinlei MiGilead Science, Inc, Foster City, USA.
Jianhua HuDepartment of Biostatistics, Columbia University, New York, USA.
Fei ZouDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, USA.
Baiming ZouDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, USA. bzou@email.unc.edu.

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
Novel analysis of association between microbiome and treatment infection in AMLR01AI143886 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HU, JIANHUA · 2019 to 2023
$2.0M
Robust Computational and Data Analytic Tools for In-depth Understanding Postoperative Pain Mechanism with Enhanced Pain Management and Clinical Decision MakingR01LM014407 · NLM · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Baiming Zou · 2024 to 2026
$1.4M
Enhanced Machine Learning Tools for Complex Data Evaluation and Integration in Advancing Health OutcomesR01HL173044 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Baiming Zou, Fei Zou · 2025 to 2026
$1.3M
Multidisciplinary Training in Gastrointestinal CancersT32CA285274 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Julian Abrams, Anil K Rustgi · 2024 to 2026
$897k
Novel Deep Learning Tools for Clinical Decision Support in Postoperative Pain ManagementR56LM013784 · NLM · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZOU, BAIMING · 2022 to 2023
$832k
NCI NIH HHS P30 CA013696NCI NIH HHS T32 CA285274NHLBI NIH HHS R01 HL173044NIAID NIH HHS R01 AI143886NIH/NLM 1R56LM013784-01A1NLM NIH HHS R01 LM014407NLM NIH HHS R56 LM013784
6 · The paper itself

Abstract

The integration of drug molecular representations into predictive models for Drug Response Prediction (DRP) is a standard procedure in pharmaceutical research and development. However, the comparative effectiveness of combining these representations with genetic profiles for DRP remains unclear. This study conducts a comprehensive evaluation of the efficacy of various drug molecular representations employing cutting-edge machine learning models under various experimental settings. Our findings reveal that the inclusion of molecular representations from either PubChem fingerprints or SMILES can significantly enhance the performance of DRPs when used in conjunction with deep learning models. However, the optimal choice of drug molecular representation can vary depending on the predictive model and the specific DRP task. The insights derived from our study offer useful guidance on selecting the most suitable drug molecular representations for constructing efficient predictive models for DRPs, aiding for drug repurposing, personalized medicine, and new drug discovery.

Indexed as

Drug DiscoveryMachine LearningDeep LearningDrug RepositioningHumansPharmaceutical PreparationsPrecision MedicinePharmaceutical Preparations

Identifiers

PMID39748003
PMCPMC11696021

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.